APAP hepatotoxicity occurs through formation of the noxious NAPQI metabolite, which is present in excessive quantities, as augmented by features of glutathione (GSH) depletion, oxidative stress and mitochondrial dysfunction leading to depletion in adenosine triphosphate (ATP) stores
Cycle Length: Commonly 812 weeks , followed by a short break before repeating an evaluation phase
In TRIUMPH-4, dysesthesia (abnormal sensations: tingling, prickling, burning, numbness) was reported by 8,8% of participants in the 9 mg dose range and 20,9% of participants in the 12 mg dose range
O'DonnellCPAllottKAMurphyBPYuenHPProffittTMPapasAet al
Semaglutide continues to provide appetite suppression, metabolic benefits, and weight loss efficacy even after side effects have resolved, confirming that the mechanisms of benefit are distinct from the mechanisms of transient side effects